A carregar...
Adalimumab
Adalimumab, an entirely human monoclonal antibody, specifically blocks the cell-surface receptor relationship of tumor necrosis factor-alpha (TNF-α) with p55 and p75 TNF-α, thereby suppressing the biological activity of TNF-α. It received FDA approval in 2008 for the treatment of moderate to severe...
Na minha lista:
Autor principal: | |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Galenos Publishing House
2022-04-01
|
Colecção: | Turkderm Turkish Archives of Dermatology and Venereology |
Assuntos: | |
Acesso em linha: | https://journal.turkderm.org.tr/jvi.aspx?un=TURKDERM-59487&volume=56&supp=1 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|